Navigation Links
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Date:2/5/2009

vessel in-stent restenosis and major adverse coronary events (MACE) in patients treated with the TAXUS Liberte Atom Stent, and a significantly reduced rate of myocardial infarction (heart attack) in patients with long lesions treated with the TAXUS Liberte Long Stent.

"In the ATLAS study, lower target lesion revascularization (TLR) rates contributed to a significantly lower rate of MACE, including heart attacks, with the TAXUS Liberte Atom Stent," said Mark A. Turco, M.D., Director of the Center for Cardiac and Vascular Research, Washington Adventist Hospital, and Co-Principal Investigator of the ATLAS trial. "The thinner struts of the TAXUS Liberte Atom Stent are designed to improve its deliverability and conformability, which is important when treating small vessels. The TAXUS Liberte Stent also features an advanced stent cell geometry that has been designed to allow for more consistent drug distribution."

Patients with small vessels treated with the TAXUS Liberte Atom Stent reported significantly lower nine-month angiographic in-segment late loss (0.16 mm vs. 0.32 mm, p=0.0146), reduced nine-month angiographic restenosis (18.5% vs. 32.7%, p=0.0219), reduced 12-month TLR (6.1% vs. 16.9%, p=0.0039), and reduced rates of stent thrombosis (0.4% vs. 1.5%, p=0.39). Patients with long lesions treated with the TAXUS Liberte Long Stent reported a significantly reduced 12-month rate of myocardial infarction (1.4% vs. 6.5%, p= 0.0246) as well as a trend toward fewer stent thromboses (0% vs. 0.7%, p=0.48).

"We are pleased to have a second-generation small vessel DES and the U.S. market's first long DES under review by the FDA," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "The rapid adoption of our recently approved TAXUS Express Atom Stent confirms the need for an expanded DES size matrix to treat the wide range of vessel anatomies seen in daily clinical practice."

Bosto
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
2. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
3. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
4. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
5. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
6. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
8. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
9. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
10. Leading Immunologists Convene in Boston
11. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global A Dialyzer ... 2014" report to their offering. ... Reprocessor ) Industry Report 2014 is a professional ... the A dialyzer reprocessing machine industry. The ...
(Date:6/1/2015)... N.Y. , June 1, 2015 ... HRTX ) today announced positive, top-line results ... MAGIC evaluated the efficacy and safety of the ... SUSTOL ® (granisetron injection, extended release) as ... (IV) neurokinin-1 (NK 1 ) receptor antagonist fosaprepitant ...
(Date:6/1/2015)... CLEVELAND , June 1, 2015 Researchers ... and Case Western Reserve University School of Medicine will ... evaluating a potential novel combination treatment for cancer patients ... gene mutations in small cell lung cancer (SCLC), at ... (ASCO) Annual Meeting in Chicago . ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3New cancer therapy study results - MAGIC Trial 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3
... New results from an observational substudy from ... Association (AHA) Scientific Sessions annual meeting showed that ... artery bypass graft surgery (CABG) had a reduced ... Plavix® (clopidogrel) (2.3 percent versus 8.7 percent respectively, ...
... one of the world,s leading research and advisory firms ... the launch of several novel agents, the hepatitis C ... approximately $2 billion in 2009 to nearly $7.5 billion ... Spain, the United Kingdom and Japan. Thereafter, the market ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 2The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 3
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... New York, NY (PRWEB) June 02, 2015 ... leader in minimally invasive spine surgery with three locations ... office in New York City. The new facility is ... York, N.Y. 10028. Telephone consultations and appointments can be ... founder and chief surgeon at Atlantic Spine Center, has ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Pacifica ... fund set up by current and former students to ... beloved faculty member from 2002 until his death in ... intelligence, and depth of feeling, as well as his ... His capacities as an analyst, teacher, and writer were ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in business. NAPW is the nation’s leading networking ... members and over 200 operating Local Chapters. , “I’m ... NAPW President Star Jones. “Job satisfaction is essential for ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into the NAPW VIP ... with this prestigious distinction for leadership in academics. With ... Chapters, NAPW is the nation’s leading networking organization exclusively ... with this important distinction,” said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... , INDIANAPOLIS, Sept. 9 WellPoint, Inc. (NYSE: ... Medicare Advantage and 2010 Medicare Part D health benefit plans effective Oct. ... Medicare Part D health benefit plans on Nov. 15, 2009 for the ... Medicare and Medicaid Services (CMS) has determined that WellPoint has corrected deficiencies ...
... approval of second HPV vaccine, Cervarix, to prevent cervical cancer ... recommended Wednesday that use of the vaccine Gardasil, already administered ... help prevent genital warts in young males. , A U.S. ... expanded use of the vaccine for males 9 to 26. ...
... , WASHINGTON, Sept. 9 San Francisco Mayor ... tonight for the President,s historic speech on healthcare reform before a ... As Co-Chair of the U.S. Conference of Mayors Healthcare ... mayors around the country to urge Congress to pass comprehensive health ...
... dormant, common virus that crosses over into brain , WEDNESDAY, ... of the reason why Tysabri, a drug used to treat ... but potentially deadly brain disease in some patients. , The ... its slumber, allowing it to cross into the brain. , ...
... Sept. 9 Stryker Corporation (NYSE: SYK ) announced ... 20, 2009, at 4:30 p.m., Eastern Time, to discuss the Company,s ... an operational update. Operating results for the quarter ended September 30, ... , To participate in the conference call dial 800-706-7745 ...
... , PITTSBURGH, Sept. 9 The California ... host filmmaker Michael Moore at a special reception Monday night, along ... A Love Story" at the AFL-CIO national convention in Pittsburgh. , ... will outline the ongoing campaign for single payer healthcare reform by ...
Cached Medicine News:Health News:Statement on WellPoint's Re-Entry into Medicare Market 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 3Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 4Health News:Mayor Gavin Newsom to Be President Obama's Guest for Healthcare Reform Speech to the Nation 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:Stryker To Host Conference Call on October 20, 2009 2Health News:Nurses, AFL-CIO Unions to Host Michael Moore and Special Screening of New Film at AFL-CIO Convention 2
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: